Background
==========

Chronic inflammatory bowel disease (IBD) and Lynch syndrome (LS) are associated with an increased risk for developing colorectal cancer (CRC). After 8-10 years of pan-ulcerative colitis (DC), the risk of CRC is 2%, increasing by 0.5-1.0% annually. LS has been associated with a 60-80% lifetime risk of CRC. It is unclear whether individuals diagnosed with both IBD and LS would have a cumulative risk or earlier age of onset of CRC based on their diagnoses.

Method
======

Patients with IBD and a germline mismatch repair gene (MMR) mutation were identified through the Familial Gastrointestinal Cancer Registry at Mount Sinai Hospital in Toronto, Canada. Information on their IBD diagnosis, colorectal screening/surgery, medication use, family history and genetic test results were collected (Table [1](#T1){ref-type="table"}).

  Case \#                                        1           2            3            4                   5
  -------------------------------- ------------- ----------- ------------ ------------ ------------------- -------------------
  Gender                                         M           F            F            M                   F
  Ethnicity                                      Caucasian   Jewish       Caucasian    Caucasian           Caucasian
  MMR Mutation                                   MLH1        MSH2         MSH2         MSH2                MSH6
  Age of IBD dx                                  27          20           27           32                  23
  Site of IBD                                    Ileum       Pancolitis   Pancolitis   Proctitis           Pancolitis
  Colectomy, age                                 21          57           43           44                  63
  Cancer/dysplasia                               CRC dx 21   LGC\*        None         TVA/HGD\*\* dx 44   Endometrial dx 57
  Smoking hx                                     N           Y            N            Y                   N
  IBD medication                   5-ASA         N           Y            Y            Y                   Y
                                   Steroids      N           Y            Y            N                   Y
                                   Antibiotics   N           Y            Y            Y                   N
  Age of CRC in 1^0^ or 2^0^ kin   \# of kin     2           3            2            4                   5
                                   Mean age      40.5        30.7         35.5         49.7                78.4

\*LGD -- low-grade dysplasia on random screening biopsy

\*\*TVA/HGD -- tubulovillous adenoma with foci of high-grade dysplasia

Results
=======

Five of 329 (1.5%) individuals with germline MMR mutations reported having a history of IBD.

Conclusions
===========

Concurrent IBD and LS did not appear to predispose to early-onset CRC in our small case series.
